Discover how Aletta® sets a new standard for blood collection
Aletta®, the world’s first Autonomous Robotic Phlebotomy Device® (ARPD®), automates the diagnostic blood collection process.
Addresses staffing shortages
Aletta® is designed to reduce workload, improve efficiency, and enhance the patient experience.
Performs a fully autonomous blood draw
Aletta® performs the entire blood draw on its own, from placing the tourniquet to applying the bandage.
Supports large-volume sites
One trained phlebotomist can oversee up to three Aletta® devices, making it ideal for busy blood draw centers.
Automating phlebotomy with Aletta® ARPD®
Aletta® is designed to perform the complete blood draw procedure autonomously. This includes identification of a suitable vein, inserting the needle, changing and inverting the tubes, and placing the bandage.
To locate a suitable vein, Aletta® uses multimodal imaging that combines near infrared and ultrasound. In addition, the device uses Doppler ultrasound to confirm it has selected a vein and not an artery. Then, Aletta® positions and inserts the needle with submillimeter precision.
By automating these steps, Aletta® aims to improve consistency and reduce variability in blood collection. This supports the shift towards fully automated laboratory workflows.
Aletta® has been granted FDA De Novo authorization in August 2026.
Clinical Evidence, published in Clinical Chemistry
Discover the value of Aletta® ARPD® for you
For Hospital Leadership
A forward-looking approach to blood collection
Hospital and lab leadership can explore how Aletta® fits into their long term innovation planning. As Aletta® introduces a new supervised workflow for routine blood draws, phlebotomy departments shift to a standardized process.
For Laboratory Specialists
Focus on preanalytical quality
Learn how Aletta® supports blood collection through a supervised workflow. In addition, the results published in Clinical Chemistry offer insights into performance, safety, and patient acceptance.
Particularly, clinical chemists and lab managers can explore how autonomous phlebotomy is intended to strengthen preanalytical reliability, align with established laboratory processes, and bring more predictability to routine blood draws.
For Phlebotomists and Nurses
A new supervised workflow
Find out how Aletta® performs each step of a routine blood draw autonomously while staff remain in control through the supervisor role. Learn what the workflow looks like in practice.
U.S. clinical research and market research collaborators
Customer Success
Implementation and training
Patient education and engagement
Technical and professional services
¹ Giesen, L.F.P., Roest, J.A., et al. Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial. Clinical Chemistry (2026)
Note: this study evaluated an investigational version of the device. The results have not been reviewed by the FDA.